We are 90% efficient with phase 3 trials : Pfizer

Listen to this article - Play Now
Spread the Chronicle

We are 90% efficient with phase 3 trials: says Pfizer as it announced this statement yesterday 

The American pharmaceutical industry Pfizer has recently announced that their vaccine for COVID 19 has been 90% efficient with phase three trails. The company however did not release any further information regarding the initial and final rates of the vaccine so far. 

On track this month 

The company also informed that the 90% positive shots are an indication that the company is on track in finding a positive vaccine and to contact an emergency release with the US regulators.  

Though the company did not ensure that the vaccine is prominent in near future as a source informed that the rate of cure of the vaccine might change from initial to final state as this is only the testing phase.  

94 infections 

An independent data monitoring board, looked at 94 infections recorded so far in a study that has enrolled nearly 44,000 people in the US and five other countries. The company gave no information about the infections registered. 

We’re encouraged 

Pfizer’s senior vice president of clinical development Dr.Bill Gruber said to the Associated press that.” We’re very encouraged”, as the company might give us a hope against the virus affecting humanity so far. 

A collaborative effort 

The vaccine is a collaborative work between Pfizer and BioNTech have started testing all over the world by distributing their product to other pharma companies like Moderna inc, etc. And now with these positive notes, world is definitely marching towards a Covid less future. 

What do you feel about all these vaccines under R&D right now? Will these be successful somewhere? When can we expect a real vaccine? 

Comment your thoughts below and join us in the discussion. 

Spread the Chronicle

Leave a Reply

Your email address will not be published. Required fields are marked *